Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 18.35
+0.11 (0.60%)
Mar 30, 2026, 3:00 PM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 3.06 billion as of March 30, 2026. Its market cap has decreased by -22.38% in one year.
Market Cap
3.06B
Enterprise Value
2.92B
Revenue
574.88M
Ranking
n/a
PE Ratio
19.52
Stock Price
18.35
Market Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 3.06B, a decrease of -44.75%. That is a compound annual growth rate of -9.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.04B | -21.65% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yantai Zhenghai Biotechnology | 3.46B |
| Landfar Bio-medicine | 3.32B |
| Beijing Kawin Technology Share-Holding | 3.25B |
| Guangdong VTR Bio-Tech | 3.18B |
| Shanghai Model Organisms Center | 3.09B |
| Jiangsu Sihuan Bioengineering | 3.04B |
| Shanghai Hile Bio-Technology | 3.01B |
| Suzhou Fushilai Pharmaceutical | 2.85B |